5 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... body mass index; VTE ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... thrombosis in cancer ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
post-thrombotic syndrome ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... anticoagulation #duration #management ... #DVT #hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... at 3 Months • Cancer ... therapy - Second VTE ... Thromboembolism #Treatment #Algorithm ... #management #hematology
Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based tests:
 • FIT: 79% sensitivity, 94% specificity for CRC
for Colorectal Cancer ... and Hepatology ... #Colorectal #Cancer ... Tests #comparison #table ... #management #gastroenterology